0001959173-23-002171.txt : 20230703 0001959173-23-002171.hdr.sgml : 20230703 20230703101723 ACCESSION NUMBER: 0001959173-23-002171 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230703 DATE AS OF CHANGE: 20230703 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 231063903 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Watson David O. CENTRAL INDEX KEY: 0001657719 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 144 1 primary_doc.xml 144 0001657719 XXXXXXXX LIVE 0001492422 Apellis Pharmaceuticals, Inc. 001-38276 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700 Watson David O. Officer Common Fidelity Brokerage Services LLC

900 Salem Street Smithfield RI 02917

8510 765729.80 116457008 07/03/2023 NASDAQ Common 01/21/2023 Restricted Stock Vesting Issuer N 4478 01/21/2023 Compensation Common 01/28/2023 Restricted Stock Vesting Issuer N 1324 01/28/2023 Compensation Common 02/10/2023 Restricted Stock Vesting Issuer N 1062 02/10/2023 Compensation Common 02/21/2023 Restricted Stock Vesting Issuer N 1646 02/21/2023 Compensation Y 07/03/2023 03/02/2023 /s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Watson